Li Fang Hao
Président chez Jiangsu Vanguard Pharmaceutical Co., Ltd.
Profil
Li Fang Hao is currently the Chairman-Supervisory Board & Manager at Jiangsu Vanguard Pharmaceutical Co., Ltd.
Postes actifs de Li Fang Hao
| Sociétés | Poste | Début |
|---|---|---|
Jiangsu Vanguard Pharmaceutical Co., Ltd.
 Jiangsu Vanguard Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Jiangsu Vanguard Pharmaceutical Co., Ltd. engages in the research, development, production and sale of chemical drugs and proprietary Chinese medicines. Its products include valsartan hydrochlorothiazide tablets, calcium dobesilate capsules, calcium carbonate D3 chewable tablets, irbesartan hydrochlorothiazide tablets, bezafibrate dispersible tablets, aluminum magnesium carbonate chewable tablets, amlodipine maleate dispersible tablets, brucei seed oil soft capsules. The company was founded by Guang Xue He on November 28, 2003 and is headquartered in Nantong, China. | Président | 01/05/2018 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Jiangsu Vanguard Pharmaceutical Co., Ltd.
Jiangsu Vanguard Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Jiangsu Vanguard Pharmaceutical Co., Ltd. engages in the research, development, production and sale of chemical drugs and proprietary Chinese medicines. Its products include valsartan hydrochlorothiazide tablets, calcium dobesilate capsules, calcium carbonate D3 chewable tablets, irbesartan hydrochlorothiazide tablets, bezafibrate dispersible tablets, aluminum magnesium carbonate chewable tablets, amlodipine maleate dispersible tablets, brucei seed oil soft capsules. The company was founded by Guang Xue He on November 28, 2003 and is headquartered in Nantong, China. | Health Technology |
